Lv5
810 积分 2025-06-05 加入
Elevated High-Sensitivity C-Reactive Protein and Dyslipidaemia in Type 2 Diabetes Mellitus: Implications for Cardiovascular Risk Prediction in Nigerian Patients
1天前
待确认
Association of novel inflammatory and metabolic markers with mortality in individuals with overweight and obesity
1天前
已完结
Novel metabolic and inflammatory stratification of overweight/obesity to characterize risks of adverse outcomes: A large population‐based cohort study
1天前
已完结
White adipocyte dysfunction and obesity-associated pathologies in humans
4天前
已完结
The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis
5天前
已完结
Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy: A Retrospective Cohort Study
5天前
已完结
Early Adjuvant Treatment with Semaglutide After Sleeve Gastrectomy in Patients with Class II-III Obesity: A Prospective Non-Randomized Controlled Study
5天前
已完结
Deciphering adipose development: Function, differentiation and regulation
6天前
已完结
Endothelial dysfunction is a risk factor for lipid metabolism disorders: underlying mechanisms and potential treatments
6天前
已完结
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
18天前
已完结
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
4个月前
已采纳
Research Summary Neoadjuvant GOLP in Intrahepatic Cholangiocarcinoma
4个月前
已采纳
Research Summary Neoadjuvant GOLP in Intrahepatic Cholangiocarcinoma
4个月前
已驳回
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
4个月前
已撤回
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
4个月前
已采纳
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
4个月前
已采纳
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
4个月前
已采纳
Floppy Eyelid Syndrome
5个月前
已采纳
Beta-Blockers after Myocardial Infarction — Toward Personalized Management
5个月前
已采纳
Elective Cesarean Section for Maternal Preference
5个月前
已采纳
皖公网安备34019202002308
